The Role of Iduna in Neuroprotection
Iduna 在神经保护中的作用
基本信息
- 批准号:7275931
- 负责人:
- 金额:$ 39.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-15 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAlzheimer&aposs DiseaseAmericanAmyotrophic Lateral SclerosisAnimal ModelAnimalsApoptosisApoptoticAreaAtaxiaAttentionCause of DeathCell DeathCell SurvivalCellsCessation of lifeCultured CellsDiseaseEpilepsyFutureGenesGoalsHealedHuntington DiseaseIncidenceIndividualInfarctionInjuryIschemiaLearningMediatingMedicalModelingNamesNeurologicNeuronsParkinson DiseasePathway interactionsPharmacologic SubstancePlayProteinsQuality of lifeRangeRare DiseasesRegulationResearch PersonnelResistanceRoleSerumSignal PathwaySignal TransductionSignal Transduction PathwayStaurosporineStrokeTissuesTransgenic MiceWithdrawalWorld Health Organizationcell injurycostcytotoxicitydisabilityexcitotoxicityhealingin vivomouse modelnervous system disorderneuroprotectionnovelpreconditioningprogramsprotein expressionprotein protein interactionrelating to nervous system
项目摘要
DESCRIPTION (provided by applicant): There are approximately 250 neurological - brain and nervous system - disorders. Combined, neurologic disorders are the leading cause of death, disability and loss of quality of life worldwide according to the World Health Organization. The incidence of these disorders ranges from stroke, epilepsy and Alzheimer's, which affect millions, to rare diseases such as amyotrophic lateral sclerosis and ataxia's. To address the problem of brain and nervous system disorders investigators have focused attention on describing cell injury mechanisms. However, discovery of cell survival strategies could have profound impact on the treatment of neurologic disorders and disease and is an area that has not yet been rigorously investigated. Recently we developed a strategy to discover neuroprotective genes from preconditioned neural tissue. Some of the first genes we have begun to characterize provide protection not only against ischemic and excitotoxic injury but are protective against classic apoptotic injury triggered by staurosporin or serum withdrawal. This is very exciting, suggesting that it might be possible to find molecules that are broadly protective and therefore might provide treatment for stroke and perhaps even for other neurologic disorders such as Parkinson's disease, Huntington's disease or ALS. From this screen we identified a protein of unknown function that is potently neuroprotective that we have named Iduna and proposed the following aims to explore the biologic function of Iduna.
Aim 1: What is the anatomical and cellular localization of Iduna in control and preconditioned tissues? Aim 2: What are the death programs against which Iduna protects neurons?
Aim 3: Is Iduna neuroprotective in vivo?
Aim 4: What is the neuroprotective network of Iduna?
On completion of these studies we will have identified the biologic actions of Iduna and the survival pathways it mediates, as well as, identified potential disease targets that might benefit from expression of Iduna. Our long-term goal is to understand novel enodgenous survival pathways so that these pathways can be exploited for the treatment of neurologic injury and disease. The goal is to understand the function of Iduna so that translational therapy can be developed.
描述(由申请人提供):大约有 250 种神经系统 - 大脑和神经系统 - 疾病。根据世界卫生组织的数据,神经系统疾病是全世界死亡、残疾和生活质量下降的主要原因。这些疾病的发病率包括影响数百万人的中风、癫痫和阿尔茨海默氏症,以及肌萎缩侧索硬化症和共济失调等罕见疾病。为了解决大脑和神经系统疾病的问题,研究人员将注意力集中在描述细胞损伤机制上。然而,细胞生存策略的发现可能对神经系统疾病的治疗产生深远的影响,并且是一个尚未经过严格研究的领域。最近,我们开发了一种策略,从预处理的神经组织中发现神经保护基因。我们已经开始表征的一些第一批基因不仅提供针对缺血性和兴奋性毒性损伤的保护,而且还针对星形孢菌素或血清撤退引发的经典细胞凋亡损伤提供保护。这是非常令人兴奋的,表明有可能找到具有广泛保护作用的分子,从而可以治疗中风,甚至可能治疗其他神经系统疾病,如帕金森病、亨廷顿病或肌萎缩侧索硬化症。从这个筛选中,我们鉴定了一种功能未知的蛋白质,该蛋白质具有有效的神经保护作用,我们将其命名为 Iduna,并提出以下目标来探索 Iduna 的生物学功能。
目标 1:Iduna 在对照组织和预处理组织中的解剖学和细胞定位是什么?目标 2:Iduna 保护神经元免受哪些死亡程序影响?
目标 3:Iduna 在体内具有神经保护作用吗?
目标 4:Iduna 的神经保护网络是什么?
完成这些研究后,我们将确定 Iduna 的生物学作用及其介导的生存途径,并确定可能受益于 Iduna 表达的潜在疾病靶点。我们的长期目标是了解新的内源性生存途径,以便利用这些途径来治疗神经损伤和疾病。目标是了解 Iduna 的功能,以便开发转化疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VALINA L. DAWSON其他文献
VALINA L. DAWSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VALINA L. DAWSON', 18)}}的其他基金
Innate immune memory promotes neural damage in the ART suppressed HIV infected brain
先天免疫记忆促进 ART 抑制的 HIV 感染大脑中的神经损伤
- 批准号:
10701935 - 财政年份:2022
- 资助金额:
$ 39.76万 - 项目类别:
Imaging Mass Spectrometry-Based Metabolomic Analysis of the Alzheimer's Brain
基于成像质谱的阿尔茨海默病大脑代谢组学分析
- 批准号:
10516253 - 财政年份:2022
- 资助金额:
$ 39.76万 - 项目类别:
Innate immune memory promotes neural damage in the ART suppressed HIV infected brain
先天免疫记忆促进 ART 抑制的 HIV 感染大脑中的神经损伤
- 批准号:
10536461 - 财政年份:2022
- 资助金额:
$ 39.76万 - 项目类别:
Imaging Mass Spectrometry-Based Metabolomic Analysis of the Alzheimer's Brain
基于成像质谱的阿尔茨海默病大脑代谢组学分析
- 批准号:
10705238 - 财政年份:2022
- 资助金额:
$ 39.76万 - 项目类别:
Targeting cell signaling pathways to disrupt drug abuse
靶向细胞信号通路以破坏药物滥用
- 批准号:
10404512 - 财政年份:2018
- 资助金额:
$ 39.76万 - 项目类别:
Targeting cell signaling pathways to disrupt drug abuse
靶向细胞信号通路以破坏药物滥用
- 批准号:
10171821 - 财政年份:2018
- 资助金额:
$ 39.76万 - 项目类别:
Thorase Regulation of the Actions of Cocaine
Thorase 对可卡因作用的调节
- 批准号:
10404517 - 财政年份:2018
- 资助金额:
$ 39.76万 - 项目类别:
Thorase Regulation of the Actions of Cocaine
Thorase 对可卡因作用的调节
- 批准号:
10171826 - 财政年份:2018
- 资助金额:
$ 39.76万 - 项目类别:
Action of SARS CoV2 in Human Brain Cultures
SARS CoV2 在人脑培养物中的作用
- 批准号:
10173327 - 财政年份:2018
- 资助金额:
$ 39.76万 - 项目类别:
Characterization of a novel Flpo recombinase line targeting nigral dopamine neurons
靶向黑质多巴胺神经元的新型 Flpo 重组酶系的表征
- 批准号:
9434206 - 财政年份:2017
- 资助金额:
$ 39.76万 - 项目类别:
相似国自然基金
小胶质细胞特异罕见易感突变介导相分离影响阿尔茨海默病发病风险的机制
- 批准号:82371438
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
OATPs介导Aβ/p-Tau转运对阿尔茨海默病病理机制形成及治疗影响的研究
- 批准号:82360734
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
超细颗粒物暴露对阿尔茨海默病的影响及其机制研究
- 批准号:82373532
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于个体水平的空气环境暴露组学探讨影响阿尔茨海默病的风险因素
- 批准号:82304102
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
利用小鼠模型研究Y染色体丢失对阿尔茨海默病的影响及分子机制
- 批准号:32260148
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 39.76万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 39.76万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 39.76万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 39.76万 - 项目类别: